WAKIX Reliance Will Invite Patent Expiry And Pricing Woes
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
08 May 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
US$31.00
17.8% overvalued intrinsic discount09 Aug
US$36.51
1Y
3.6%7D
6.8%